DK3937948T3 - Phytoecdysoner og derivater deraf til anvendelse i behandlingen af neuromuskulære sygdomme - Google Patents

Phytoecdysoner og derivater deraf til anvendelse i behandlingen af neuromuskulære sygdomme Download PDF

Info

Publication number
DK3937948T3
DK3937948T3 DK20709594.4T DK20709594T DK3937948T3 DK 3937948 T3 DK3937948 T3 DK 3937948T3 DK 20709594 T DK20709594 T DK 20709594T DK 3937948 T3 DK3937948 T3 DK 3937948T3
Authority
DK
Denmark
Prior art keywords
phytoecdysones
derivatives
treatment
neuromuscular diseases
neuromuscular
Prior art date
Application number
DK20709594.4T
Other languages
English (en)
Inventor
Mathilde Latil
Pierre Dilda
René LAFONT
Stanislas Veillet
Original Assignee
Biophytis
Univ Sorbonne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biophytis, Univ Sorbonne filed Critical Biophytis
Application granted granted Critical
Publication of DK3937948T3 publication Critical patent/DK3937948T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK20709594.4T 2019-03-15 2020-03-12 Phytoecdysoner og derivater deraf til anvendelse i behandlingen af neuromuskulære sygdomme DK3937948T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1902726A FR3093640B1 (fr) 2019-03-15 2019-03-15 Phytoecdysones et leurs dérivés pour leur utilisation dans le traitement de maladies neuromusculaires
PCT/EP2020/056590 WO2020187678A1 (fr) 2019-03-15 2020-03-12 Phytoecdysones et leurs dérivés pour leur utilisation dans le traitement de maladies neuromusculaires

Publications (1)

Publication Number Publication Date
DK3937948T3 true DK3937948T3 (da) 2024-01-08

Family

ID=67660223

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20709594.4T DK3937948T3 (da) 2019-03-15 2020-03-12 Phytoecdysoner og derivater deraf til anvendelse i behandlingen af neuromuskulære sygdomme

Country Status (14)

Country Link
US (1) US12440500B2 (da)
EP (1) EP3937948B1 (da)
JP (1) JP7690395B2 (da)
KR (1) KR20210141579A (da)
CN (1) CN113766920A (da)
BR (1) BR112021018222A2 (da)
CA (1) CA3133227A1 (da)
DK (1) DK3937948T3 (da)
ES (1) ES2966716T3 (da)
FR (1) FR3093640B1 (da)
MX (1) MX2021011151A (da)
PL (1) PL3937948T3 (da)
PT (1) PT3937948T (da)
WO (1) WO2020187678A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3078252B1 (fr) * 2018-02-28 2020-08-14 Biophytis Phytoecdysones pour leur utilisation dans la prevention de la perte de force musculaire lors d’une immobilisation
FR3128873B1 (fr) 2021-11-10 2026-01-16 Biophytis Phytoecdysones et/ou dérivés de 20-hydroxyecdysone en combinaison avec un principe actif visant à restaurer l’expression SMN pour leur utilisation dans le traitement de l’amyotrophie spinale

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004137207A (ja) * 2002-10-18 2004-05-13 Keio Gijuku 細胞毒性を抑制する蛋白質
BR112012009801A8 (pt) * 2009-10-30 2016-08-30 Cns Therapeutics Inc Polipeptídeo neurturina e variante de neurturina
DK2861212T3 (da) * 2012-06-13 2017-03-06 Cerion Llc Nanopartikler af ceriumoxid til behandling af oxidativ stress
FR3021318B1 (fr) * 2014-05-20 2017-04-28 Inst Biophytis Produits derives de la 20-hydroxyecdysone et leur utilisation dans la preparation de medicaments
US9700589B2 (en) * 2015-02-03 2017-07-11 Naturex Sa Compositions and methods for improved muscle metabolism
FR3065644B1 (fr) * 2017-04-28 2020-02-21 Biophytis Extrait de 20-hydroxyecdysone de qualite pharmaceutique, son utilisation et sa preparation

Also Published As

Publication number Publication date
BR112021018222A2 (pt) 2021-11-23
PL3937948T3 (pl) 2024-04-08
PT3937948T (pt) 2024-01-02
US12440500B2 (en) 2025-10-14
CA3133227A1 (fr) 2020-09-24
FR3093640B1 (fr) 2021-10-01
US20220160732A1 (en) 2022-05-26
EP3937948A1 (fr) 2022-01-19
CN113766920A (zh) 2021-12-07
JP2022525228A (ja) 2022-05-11
JP7690395B2 (ja) 2025-06-10
EP3937948B1 (fr) 2023-09-27
WO2020187678A1 (fr) 2020-09-24
MX2021011151A (es) 2022-01-19
KR20210141579A (ko) 2021-11-23
ES2966716T3 (es) 2024-04-23
FR3093640A1 (fr) 2020-09-18

Similar Documents

Publication Publication Date Title
HUE066282T2 (hu) Heterobiciklusos MAT2A-gátlók és eljárások rák kezelésében történõ alkalmazásukra
DK3947375T3 (da) Imidazolonylquinolinforbindelser og terapeutiske anvendelser deraf
DK3858977T5 (da) Stamme til forebyggelse og behandling af stofskiftesygdomme, og brugen heraf
HUE061834T2 (hu) MAT2A aza-heterobiciklusos inhibitorai és alkalmazási eljárások rák kezelésére
DK4014976T3 (da) Aprocitentan til anvendelse i behandlingen af hypertension og relaterede sygdomme i kombination med valsartan
DK3377637T3 (da) Sammensætninger til anvendelse i fremgangsmåder til behandling af sår, lidelser og sygdomme i huden
EP3601285A4 (en) THERAPEUTIC AGENT FOR THE INHIBITION OF PHOSPHODIESTERASE AND ITS RELATED DISORDERS
IL287796A (en) Compositions and methods for the treatment of atpase-mediated diseases
IL269158A (en) Compositions and methods for treating inflammatory diseases
DK3303339T3 (da) Pde9-inhibitorer med imidazotriazinonskelet og imidazopyrazinonskelet til behandling af perifere sygdomme
PT3681857T (pt) Fluorofenil-beta-hidroxietilaminas e sua utilização no tratamento de hiperglicemia
IL280475A (en) A pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related disease
IL269083A (en) Methods for preventing and treating heart disease
DK3790879T3 (da) Triazolopyrimidinforbindelser og deres anvendelse til behandling af kræft
DK3362449T3 (da) Sibirilin-derivater til anvendelse til at forebygge og/eller behandle lidelser associeret med cellulær nekroptose
EP3625245A4 (en) PEPTIDIC COMPOUNDS, CONJUGATE COMPOUNDS AND THEIR USES IN THE TREATMENT OF INFLAMMATORY DISEASES
DK3861985T3 (da) Sammensætninger og fremgangsmåder til behandling af øjensygdomme
DK3807316T3 (da) Sammensætninger og fremgangsmåder til behandling af cancer
DK3986419T3 (da) Boronsyre-derivater og terapeutiske anvendelser heraf
DK3784210T3 (da) Topisk farmaceutisk sammensætning til behandling af analfissurer og hæmorider
DK3810128T3 (da) Sammensætninger til behandling og/eller forebyggelse af proteinaggregeringssygdomme
IL289371A (en) Methylthioninium for use in the treatment of synaptopathies
DK3722291T3 (da) Indolinonforbindelser og deres anvendelse i behandlingen af fibrotiske sygdomme
DK3476395T3 (da) Injicerbar sammensætning omfattende fibroblaster til anvendelse i behandlingen af hjertesygdomme
IL290891A (en) Compositions and methods of treating vascular diseases